Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.
J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987.
J Immunother Cancer. 2020.
PMID: 32847986
Free PMC article.